IRWD Q1 2018 Earnings — Ironwood Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

IRWDIronwood Pharmaceuticals, Inc.

$603M

Q1 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$69M+32.6% YoY

Gross Profit

$67M96.2% margin

Operating Income

-$36M-51.9% margin

Net Income

-$43M-62.4% margin

EPS (Diluted)

$-0.29

QoQ Revenue Growth

-26.6%

Cash Flow

Operating Cash Flow

-$31M

Free Cash Flow

-$32M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$571M

Total Liabilities

$589M

Stockholders' Equity

-$18M

Cash & Equivalents

$145M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$69M	$52M	+32.6%
Gross Profit	$67M	$52M	+28.9%
Operating Income	-$36M	-$40M	+9.7%
Net Income	-$43M	-$53M	+17.8%

Revenue Segments

Collaborative Arrangements

$63M91%

Active Pharmaceutical Ingredient

$5M8%

Product

$635,0001%

Geographic Segments

J

$5M100%